Company Filing History:
Years Active: 1987-1990
Title: The Innovative Contributions of Nancy Collins
Introduction
Nancy Collins is a prominent inventor based in Larchmont, NY (US). She has made significant contributions to the field of biomedical research, particularly in the development of monoclonal antibodies. With a total of three patents to her name, her work has the potential to impact various medical applications.
Latest Patents
One of Nancy Collins' latest patents is for a monoclonal antibody (mAb) 4C, which recognizes a specific antigen, Leu 200, found in human hematopoietic tissues. This innovative antibody precipitates a series of glycoproteins with a molecular weight range of about 190,000 to 230,000 from both T- and B-cell lines. The glycoproteins resolve into four discrete bands, with their distribution varying according to the cell lines. Bands 3 and 4 predominate in T-cells, while band 2 is more prevalent in B cells. The mAb 4C has potential applications in leukemia, hematopoietic cell differentiation, and transplantation diagnoses and therapy.
Career Highlights
Nancy Collins is affiliated with the Sloan-Kettering Institute for Cancer Research, where she conducts her research and develops her innovative solutions. Her work in the field of monoclonal antibodies has garnered attention and respect from her peers.
Collaborations
Some of her notable coworkers include Bo Dupont and Yasuo Morishima, who contribute to the collaborative environment at the Sloan-Kettering Institute for Cancer Research.
Conclusion
Nancy Collins is a trailblazer in the field of biomedical research, with her innovative work on monoclonal antibodies paving the way for advancements in medical diagnostics and therapies. Her contributions are invaluable to the scientific community and hold promise for future medical breakthroughs.